Risk of site-specific cancer in incident venous thromboembolism: A population-based study

Thrombosis Research

Volumn 135, Issue 3, 2015, Pages 472-478

  Petterson, Tanya M ^a   Marks, Randolph S ^a   Ashrani, Aneel A ^a   Bailey, Kent R ^a   Heit, John A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Epidemiology; Neoplasms; Pulmonary embolism; Risk; Thrombophlebitis; Venous thrombosis

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER LOCALIZATION; CARDIOVASCULAR RISK; CHILD; COLON CANCER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; EYE CANCER; FEMALE; GENERAL HEALTH STATUS ASSESSMENT; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; INCIDENCE; INFANT; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LUNG EMBOLISM; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; MORBIDITY; MULTIPLE CANCER; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; NEWBORN; OVARY CANCER; PANCREAS CANCER; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SEX DIFFERENCE; SOFT TISSUE CANCER; STANDARDIZED MORBIDITY RATIO; STATE SURVEILLANCE EPIDEMIOLOGY AND END RESULT; STOMACH CANCER; THORAX CANCER; UROGENITAL TRACT CANCER; VENOUS THROMBOEMBOLISM; VERY ELDERLY; YOUNG ADULT; COMPLICATION; NEOPLASMS; PRESCHOOL CHILD; RISK; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; RISK; RISK FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84925806930     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.12.013     Document Type: Article

References (59)

1. S. Bouillaud De l'Obliteration des veines et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et general Arch Gen Med 1 1823 188 204
2. A. Trousseau Phlegmasia ad. Clinique Medicale de l'Hotel-Dieu de Paris 1865 Bailliere Paris, France 654 712
3. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 2000 809 815
4. A. Cogo, E. Bernardi, P. Prandoni, B. Girolami, F. Noventa, and P. Simioni Acquired risk factors for deep-vein thrombosis in symptomatic outpatients Arch Intern Med 154 1994 164 168
5. F.R. Rosendaal Risk factors for venous thrombotic disease Thromb Haemost 82 1999 610 619
6. M.M. Samama An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study Arch Intern Med 160 2000 3415 3420
7. J.W. Blom, C.J. Doggen, S. Osanto, and F.R. Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722 10.1001/jama.293.6.715
8. D.P. Cronin-Fenton, F. Sondergaard, L.A. Pedersen, J.P. Fryzek, K. Cetin, and J. Acquavella Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006 Br J Cancer 103 2010 947 953 10.1038/sj.bjc.6605883
9. A.J. Walker, T.R. Card, J. West, C. Crooks, and M.J. Grainge Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases Eur J Cancer 49 2013 1404 1413 10.1016/j.ejca.2012.10.021
10. J.W. Blom, J.P. Vanderschoot, M.J. Oostindier, S. Osanto, F.J. van der Meer, and F.R. Rosendaal Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study J Thromb Haemost 4 2006 529 535 10.1111/j.1538-7836.2006.01804.x
11. J.A. Heit, W.M. O'Fallon, T.M. Petterson, C.M. Lohse, M.D. Silverstein, and D.N. Mohr Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study Arch Intern Med 162 2002 1245 1248
12. R.H. White, H. Zhou, S. Murin, and D. Harvey Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996 Thromb Haemost 93 2005 298 305 10.1267/THRO05020298
13. F.A. Spencer, D. Lessard, C. Emery, G. Reed, and R.J. Goldberg Venous thromboembolism in the outpatient setting Arch Intern Med 167 2007 1471 1475 10.1001/archinte.167.14.1471
14. S.K. Braekkan, K.H. Borch, E.B. Mathiesen, I. Njolstad, T. Wilsgaard, and J.B. Hansen Body height and risk of venous thromboembolism: The Tromso Study Am J Epidemiol 171 2010 1109 1115 10.1093/aje/kwq066
15. G. Gussoni, S. Frasson, M. La Regina, P. Di Micco, and M. Monreal Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry Thromb Res 131 2013 24 30 10.1016/j.thromres.2012.10.007
16. M.B. Donati Cancer and thrombosis Haemostasis 24 1994 128 131
17. Y.S. Arkel Thrombosis and cancer Semin Oncol 27 2000 362 374
18. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 2007 632 634 10.1111/j.1538-7836.2007.02374.x
19. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study Arch Intern Med 159 1999 445 453
20. H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, and J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850 10.1056/NEJM200012213432504
21. H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464 10.1001/archinte.166.4.458
22. M. Monreal, C. Falga, M. Valdes, C. Suarez, F. Gabriel, and C. Tolosa Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry J Thromb Haemost 4 2006 1950 1956 10.1111/j.1538-7836.2006.02082.x
23. I.A. Naess, S.C. Christiansen, P. Romundstad, S.C. Cannegieter, F.R. Rosendaal, and J. Hammerstrom Incidence and mortality of venous thrombosis: a population-based study J Thromb Haemost 5 2007 692 699 10.1111/j.1538-7836.2007.02450.x
24. C.P. Gross, D.H. Galusha, and H.M. Krumholz The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients J Gen Intern Med 22 2007 321 326 10.1007/s11606-006-0019-x
25. F. Dentali, W. Ageno, M.G. Pierfranceschi, D. Imberti, A. Malato, and C. Nitti Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer J Thromb Haemost 9 2011 1081 1083 10.1111/j.1538-7836.2011.04259.x
26. C.E. Chee, A.A. Ashrani, R.S. Marks, T.M. Petterson, K.R. Bailey, and L.J. Melton III Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study Blood 123 2014 3972 3978 10.1182/blood-2014-01-549733
27. J.F. Timp, S.K. Braekkan, H.H. Versteeg, and S.C. Cannegieter Epidemiology of cancer-associated venous thrombosis Blood 122 2013 1712 1723 10.1182/blood-2013-04-460121
28. N. Levitan, A. Dowlati, S.C. Remick, H.I. Tahsildar, L.D. Sivinski, and R. Beyth Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine 78 1999 285 291
29. P.A. Thodiyil, and A.K. Kakkar Variation in relative risk of venous thromboembolism in different cancers Thromb Haemost 87 2002 1076 1077
30. S. Sallah, J.Y. Wan, and N.P. Nguyen Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 2002 575 579
31. F. Horsted, J. West, and M.J. Grainge Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis PLoS Med 9 2012 e1001275 10.1371/journal.pmed.1001275
32. L.J. Melton III History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274 10.1016/S0025-6196(11)63966-9
33. J.L. St Sauver, B.R. Grossardt, C.L. Leibson, B.P. Yawn, L.J. Melton III, and W.A. Rocca Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project Mayo Clin Proc 87 2012 151 160 10.1016/j.mayocp.2011.11.009
34. M.D. Silverstein, J.A. Heit, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study Arch Intern Med 158 1998 585 593
35. J.A. Heit Venous thromboembolism: disease burden, outcomes and risk factors J Thromb Haemost 3 2005 1611 1617 10.1111/j.1538-7836.2005.01415.x
36. J.A. Heit, D.N. Mohr, M.D. Silverstein, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study Arch Intern Med 160 2000 761 768
37. J.L. St Sauver, B.R. Grossardt, B.P. Yawn, L.J. Melton III, and W.A. Rocca Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project Am J Epidemiol 173 2011 1059 1068 10.1093/aje/kwq482
38. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER∗Stat Database: Incidence - SEER 9 Regs Limitied-Use, Nov 2006 Sub (1973-2009), -Limited to County Attributes - Total U.S., 1969-2004 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
39. Surveillance Research program, National Cancer Institute SEER∗Stat software (www.seer.cancer.gov/seerstat < http://www.seer.cancer.gov/seerstat >), version 6.3.6.
40. D. Kleinbaum, L. Kupper, and H. Morgenstern Epidemiologic research: principles and quantitative methods 1982 Van Nostrand Reinhold Company New York, NY
41. H. Sahai, and A. Khurshid Confidence intervals for the mean of a Poisson distribution: a review Biom J 35 1993 857 867
42. N. Breslow, J. Lubin, P. Marek, and B. Langholz Multiplicative models and cohort analysis J Am Stat Assoc 78 1983 1 12
43. R.L. Prentice Relative risk regression analysis of epidemiologic data Environ Health Perspect 63 1985 225 234
44. E. Atkinson, C. Crowson, R. Pederson, and T. Therneau Technical Report Series No. 81 Poisson Models for Person Years and Expected Rates 2008 Department of Health Science Research, Mayo Clinic Rochester, Minnesota
45. C.L. Leibson, J. Needleman, P. Buerhaus, J.A. Heit, L.J. Melton III, and J.M. Naessens Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort Med Care 46 2008 127 132 10.1097/MLR.0b013e3181589b92
46. J.F. Quevedo, J.C. Buckner, J.L. Schmidt, R.P. Dinapoli, and J.R. O'Fallon Thromboembolism in patients with high-grade glioma Mayo Clin Proc 69 1994 329 332
47. R.D. Bona Thrombotic complications of central venous catheters in cancer patients Semin Thromb Hemost 25 1999 147 155 10.1055/s-2007-994916
48. L.J. Walshe, S.F. Malak, J. Eagan, and K.A. Sepkowitz Complication rates among cancer patients with peripherally inserted central catheters J Clin Oncol 20 2002 3276 3281
49. R.S. Komrokji, N.P. Uppal, A.A. Khorana, G.H. Lyman, K.L. Kaplan, and R.I. Fisher Venous thromboembolism in patients with diffuse large B-cell lymphoma Leuk Lymphoma 47 2006 1029 1033 10.1080/10428190600560991
50. J. Murray, E. Precious, and R. Alikhan Catheter-related thrombosis in cancer patients Br J Haematol 162 2013 748 757 10.1111/bjh.12474
51. M.A. Elliott, R.C. Wolf, C.C. Hook, R.K. Pruthi, J.A. Heit, and L.L. Letendre Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombin Leuk Lymphoma 45 2004 1545 1549 10.1080/10428190410001693588
52. G.H. Ku, R.H. White, H.K. Chew, D.J. Harvey, H. Zhou, and T. Wun Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival Blood 113 2009 3911 3917 10.1182/blood-2008-08-175745
53. M. Zangari, E. Anaissie, B. Barlogie, A. Badros, R. Desikan, and A.V. Gopal Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy Blood 98 2001 1614 1615
54. A.A. Desai, N.J. Vogelzang, B.I. Rini, R. Ansari, S. Krauss, and W.M. Stadler A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma Cancer 95 2002 1629 1636 10.1002/cncr.10847
55. S.Y. Kristinsson, R.M. Pfeiffer, M. Bjorkholm, L.R. Goldin, S. Schulman, and C. Blimark Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study Blood 115 2010 4991 4998 10.1182/blood-2009-11-252072
56. K.I. Pritchard, A.H. Paterson, N.A. Paul, B. Zee, S. Fine, and J. Pater Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group J Clin Oncol 14 1996 2731 2737
57. B. Fisher, J. Dignam, N. Wolmark, A. DeCillis, B. Emir, and D.L. Wickerham Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer J Natl Cancer Inst 89 1997 1673 1682
58. S.R. Nalluri, D. Chu, R. Keresztes, X. Zhu, and S. Wu Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis JAMA 300 2008 2277 2285 10.1001/jama.2008.656
59. W. Huang, R.J. Goldberg, F.A. Anderson, C.I. Kiefe, and F.A. Spencer Secular Trends in Occurrence of Acute Venous Thromboembolism: The Worcester VTE Study (1985-2009) Am J Med 127 2014 829 839 e5 10.1016/j.amjmed.2014.03.041